Jonathan Bellet
YOU?
Author Swipe
View article: Local causal discovery in epidemiology: an application to quantifying the effect of diabetes on severe liver fibrosis in patients with viral hepatitis
Local causal discovery in epidemiology: an application to quantifying the effect of diabetes on severe liver fibrosis in patients with viral hepatitis Open
Background Estimating the controlled direct effect (CDE) from observational data is challenging when the DAG is unknown. Causal discovery methods can infer a partially oriented DAG, enabling the identification of potential adjustment sets.…
View article: Comparison of Dual Monoclonal Antibody Therapies for COVID-19 Evolution: A Multicentric Retrospective Study
Comparison of Dual Monoclonal Antibody Therapies for COVID-19 Evolution: A Multicentric Retrospective Study Open
Background: Neutralizing antibodies targeting the SARS-CoV-2 Spike protein reduce COVID-19-related risk of hospitalization, particularly in high-risk individuals. The COCOPREV-R study aimed to evaluate and compare clinical outcomes in high…
View article: Real‐world economic burden of hepatitis C and impact of direct‐acting antivirals in France: A nationwide claims data analysis
Real‐world economic burden of hepatitis C and impact of direct‐acting antivirals in France: A nationwide claims data analysis Open
Background and Aims The economic impact of managing patients with hepatitis C virus (HCV) infection remains unknown. This study aimed to assess the economic burden of chronic HCV infection from a national health insurance perspective and t…
View article: Performance of algorithms for identifying patients with chronic hepatitis B or C infection in the french health insurance claims databases using the <scp>ANRS CO22 HEPATHER</scp> cohort
Performance of algorithms for identifying patients with chronic hepatitis B or C infection in the french health insurance claims databases using the <span>ANRS CO22 HEPATHER</span> cohort Open
The validity of algorithms for identifying patients with chronic hepatitis B or C virus (HBV or HCV) infection in claims databases has been little explored. The performance of 15 algorithms was evaluated. Data from HBV‐ or HCV‐infected pat…
View article: Impact of <scp>direct‐acting</scp> antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers
Impact of <span>direct‐acting</span> antiviral treatment for hepatitis C on cardiovascular diseases and extrahepatic cancers Open
Purpose The impact of direct‐acting antivirals (DAAs) on extrahepatic complications in chronic hepatitis C (CHC) patients remains poorly described. We estimated the association of DAAs with cardiovascular events and extrahepatic cancers. M…
View article: Hepatitis C virus (HCV) incidence among men who have sex with men (MSM) living with HIV: results from the French Hospital Database on HIV (ANRS CO4-FHDH) cohort study, 2014 to 2017
Hepatitis C virus (HCV) incidence among men who have sex with men (MSM) living with HIV: results from the French Hospital Database on HIV (ANRS CO4-FHDH) cohort study, 2014 to 2017 Open
Background Despite the availability of highly effective direct-acting antivirals (DAAs) and the expected treatment as prevention (TasP) effect, transmission of hepatitis C virus (HCV) persists in men who have sex with men (MSM) who engage …
View article: Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial
Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial Open
Antiretroviral maintenance therapy 4 days a week was effective for 48 weeks in 96% of patients, leading to potential reduction of long-term toxicities, high adherence to the antiretroviral regimen and drug cost saving.